No holiday gift for GSK: FDA sends long-acting HIV injectable back to work

HIV patients hunting for relief from the burden of daily pills should wait longer. Saturday, GlaxoSmithKline's ViiV Healthcare declared that the FDA had rejected its long-acting HIV injection, known underneath of the working title Cabenuva. The statement is thin on details, noting with the exception that large response letter pertains to chemistry manufacturing and controls... Continue Reading →

Even with early treatment, HIV still attacks young brains, study says

Many children living with HIV today are in sub-Saharan Africa. While early antiretroviral therapy, or ART, has ensured less deadly outcomes for little ones managing and subject to HIV, studies show the HIV most likely will prohibit the brain. HIV may disrupt neurodevelopment, affecting how children learn, reason operates.  To get some inspiration Michael Boivin,... Continue Reading →

CDC Report: Drug Costs Linking to Nonadherence in People With HIV

As stated by the US Centers for Disease Control and Prevention (CDC), Americans pay 14% of their prescription drug costs away from pocket each year, as well as having the United States spends more per capita on pharmaceuticals compared to any high-income country in the world. High expenses help contribute to some magnitude of nonadherence among patients

HIV’s Ties to Age-Related Illnesses

A brand new medical literature review has identified a roster of aging-related medical conditions linked to HIV. The researchers reviewed 20 studies that covered HIV’s potential link to 55 health outcomes. They found that four aging-related outcomes had a statistically significant association with HIV, in other words connection is not likely to have been driven by chance. Some of these are shortness of breath, chronic obstructive pulmonary disease (COPD, a chronic inflammatory lung disease that obstructs airflow towards the lungs), anemia and bone fractures. Two... Continue Reading →

Did you know HIV from a hug is a fallacy? Misinformation persists among young Americans, study finds.

It's been four decades since the first AIDS cases were reported when you look at the U.S., but stigma against HIV-positive people persists, among younger Americans have not been alive throughout the early — and darkest — days of this epidemic.

Powered by

Up ↑

%d bloggers like this: